Skip to main content

Table 1 The extracted glycated hemoglobin and extracted glycated albumin data in the first repeated cross-sectional study

From: Changes in antidiabetic prescription patterns and indicators of diabetic control among 200,000 patients over 13 years at a single institution in Japan

Year

2001

2005

2010

2013

rs*

p value*

Measured HbA1c (n)

10,651

14,342

18,783

7846

 

HbA1c (NGSP) (%)

7.9 ± 1.4

7.9 ± 1.4

7.7 ± 1.4

7.6 ± 1.4

−0.11

<0.01

HbA1c (IFCC) (mmol/mol)

63 ± 16

63 ± 16

60 ± 15

59 ± 15

  

HbA1c (NGSP) groupa

      

 <6% (%)

615 (6)

471 (3)

935 (5)

511 (7)

  

 ≥6% and <7% (%)

1997 (19)

2786 (19)

5194 (28)

2367 (30)

  

 ≥7% and <8% (%)

3457 (33)

5238 (37)

6621 (35)

2585 (33)

  

 ≥8% (%)

4582 (43)

5847 (41)

6033 (32)

2383 (30)

 

<0.01#

Year

2003

2005

2010

2013

rs*

p value*

Measured glycated albumin (n)

8415

12,934

17,681

7463

  

Glycated albumin (%)

22.7 ± 5.3

22.5 ± 5.6

21.2 ± 5.5

20.7 ± 5.7

−0.13

<0.01

Glycated albumin quartilea

 <18% (%)

1281 (15)

2348 (18)

5173 (29)

2584 (35)

  

 ≥18% and <20.7% (%)

1919 (23)

3004 (23)

4501 (26)

1728 (23)

  

 ≥20.7% and <24.2% (%)

2487 (30)

3737 (29)

4048 (23)

1622 (22)

  

 ≥24.2% (%)

2728 (32)

3845 (30)

3959 (22)

1528 (21)

 

<0.01#

  1. Mean ± standard deviation or n (%)
  2. NGSP National Glygohemoglobin Standardization Program, IFCC The International Federation of Clinical Chemistry and Laboratory Medicine
  3. * Analysis results over 13 years; Additional file 1 shows this in detail
  4. # Using the Chi square test
  5. a Percentages in this column may not add up to exactly 100% because of rounding up